These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1667267)

  • 21. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased levels of p21WAF1/Cip1 in human brain tumors.
    Jung JM; Bruner JM; Ruan S; Langford LA; Kyritsis AP; Kobayashi T; Levin VA; Zhang W
    Oncogene; 1995 Nov; 11(10):2021-8. PubMed ID: 7478521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression.
    Lau N; Uhlmann EJ; Von Lintig FC; Nagy A; Boss GR; Gutmann DH; Guha A
    Int J Oncol; 2003 Jan; 22(1):195-200. PubMed ID: 12469204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.
    Dietzmann K; von Bossanyi P
    Zentralbl Pathol; 1994 Nov; 140(4-5):335-41. PubMed ID: 7826981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal changes and correspondingly altered proto-oncogene expression in human gliomas. Value of combined cytogenetic and molecular genetic analysis.
    Patt S; Thiel G; Maas S; Lozanova T; Prosenc N; Cervos-Navarro J; Witkowski R; Blumenstock M
    Anticancer Res; 1993; 13(1):113-8. PubMed ID: 8476201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
    Kirla RM; Haapasalo HK; Kalimo H; Salminen EK
    Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glial fibrillary acidic protein and central nervous tumors. Immunohistochemical study of a series of 207 cases. 1: Astrocytomas. Glioblastomas. Ependymomas. Papillomas of the choroid plexus].
    Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
    Ann Pathol; 1983; 3(2):127-35. PubMed ID: 6307324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
    Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Q-modification of tRNAs in human brain tumors.
    Aytaç U; Gündüz U
    Cancer Biochem Biophys; 1994 Sep; 14(2):93-8. PubMed ID: 7889496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
    Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
    Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
    Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
    Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas.
    Wharton SB; Chan KK; Whittle IR
    J Clin Neurosci; 2002 Mar; 9(2):165-9. PubMed ID: 11922706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
    Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
    Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.